NPI: 1376723262 · WINTER PARK, FL 32792 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/07/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/07/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,186 | $907K |
| 2019 | 11,810 | $575K |
| 2020 | 10,129 | $1.13M |
| 2021 | 138 | $518.88 |
| 2022 | 309 | $27K |
| 2023 | 122 | $9K |
| 2024 | 355 | $21K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,781 | 473 | $901K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 9,441 | 670 | $785K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,915 | 480 | $500K |
| A4657 | Syringe, with or without needle, each | 1,275 | 535 | $267K |
| J1756 | Injection, iron sucrose, 1 mg | 1,453 | 273 | $86K |
| 85041 | 560 | 341 | $34K | |
| 85048 | 586 | 343 | $34K | |
| 83970 | 263 | 180 | $18K | |
| 82728 | 197 | 143 | $9K | |
| 83540 | 205 | 140 | $9K | |
| 83550 | 206 | 140 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 73 | 55 | $9K |
| 82108 | 25 | 16 | $1K | |
| 82746 | 21 | 13 | $1K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 24 | 14 | $1K |
| 82607 | 24 | 15 | $843.68 |